Literature DB >> 15982304

Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis.

Andris Rubins1, Rita Gutmane, Nora Valdmane, Paul Stevenson, Claire Foster, Nasrullah Undre.   

Abstract

The systemic exposure to tacrolimus after first and repeated application of 0.1% tacrolimus ointment was investigated in 32 adults with moderate to severe atopic dermatitis. Patients were allocated to treatment groups according to the size of the affected area to be treated: Group 1</=3000 cm(2) (N=11); Group 2>3000 cm(2)</=6000 cm(2) (N=12); Group 3>6000 cm(2)</=10,000 cm(2) (N=9). Ointment was applied twice daily for 13 d and once daily on Day 14; the size of application area remained the same irrespective of healing. Blood samples were collected on Days 1 (first application), 4, and 14 (last application) and analyzed by a validated HPLC-MS/MS method. Systemic exposure to tacrolimus was generally low with 96% of blood samples assayed containing concentrations below 1 ng per mL and 23% of samples below the lower limit of quantification (0.025 ng per mL). Peak concentrations after first ointment application were </=2.8 ng per mL, and the mean area under the concentration-time curve between 0 and 12 h using the trapezoidal rule (AUC(0-12)) values were 1.1, 1.6, and 4.8 ng h per mL for Groups 1, 2, and 3, respectively. The corresponding mean values on Day 14 were similar indicating negligible systemic accumulation of tacrolimus after repeated ointment applications. Both the rate and extent of topical absorption decreased as the skin lesions healed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982304     DOI: 10.1111/j.0022-202X.2005.23754.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.

Authors:  T Hofman; N Cranswick; P Kuna; A Boznanski; T Latos; M Gold; D F Murrell; K Gebauer; U Behre; E Machura; J Olafsson; Z Szalai
Journal:  Arch Dis Child       Date:  2006-06-23       Impact factor: 3.791

Review 2.  The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis.

Authors:  Carole Guillet; Corsin Seeli; Meienberger Nina; Lara Valeska Maul; Julia-Tatjana Maul
Journal:  Int J Womens Dermatol       Date:  2022-04-13

Review 3.  Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Adelaide A Hebert
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

4.  Inpatient Management of Mucocutaneous GVHD.

Authors:  Toral Vaidya; Christian Menzer; Doris M Ponce; Alina Markova
Journal:  Curr Dermatol Rep       Date:  2019-11-11

5.  Preparation and in vitro evaluation of tacrolimus-loaded ethosomes.

Authors:  Guiling Li; Chao Fan; Xinru Li; Yating Fan; Xiaoning Wang; Mei Li; Yan Liu
Journal:  ScientificWorldJournal       Date:  2012-05-02

6.  Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution.

Authors:  Ji-Hyun Kang; Jinmann Chon; Young-Il Kim; Hyo-Jung Lee; Dong-Won Oh; Hong-Goo Lee; Chang-Soo Han; Dong-Wook Kim; Chun-Woong Park
Journal:  Int J Nanomedicine       Date:  2019-07-18

Review 7.  Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Jennifer D Kaiser; Adelaide A Hebert
Journal:  BMC Pediatr       Date:  2016-06-07       Impact factor: 2.125

Review 8.  Atopic dermatitis: a review of topical nonsteroid therapy.

Authors:  Ariana Papier; Lindsay C Strowd
Journal:  Drugs Context       Date:  2018-04-03

Review 9.  Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature.

Authors:  Sofine Heilskov; Mette S Deleuran; Christian Vestergaard
Journal:  Dermatol Ther (Heidelb)       Date:  2020-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.